Ionis Pharmaceuticals reported $243M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Agios Pharmaceuticals USD 55.38M 10.64M Sep/2026
Alnylam Pharmaceuticals USD 1.46B 170M Sep/2026
Arrowhead Research USD 450.82M 375.59M Sep/2026
Astellas Pharma JPY 629.95B 10.96B Sep/2026
BioCryst Pharmaceuticals USD 218.25M 188.3M Jun/2026
BioMarin Pharmaceutical USD 1.03B 40M Sep/2026
Celltrion KRW 1.24T 90B Jun/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Divis Laboratories Ltd INR 36.76B 9.18B Sep/2026
Exelixis USD 658.69M 30M Sep/2026
Halozyme Therapeutics USD 492.97M 11.97M Sep/2026
Ionis Pharmaceuticals USD 243M 25M Sep/2026
Kangmei Pharma CNY 1.19B 106M Jun/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Medical Developments International AUD 21.57M 12.04M Dec/2025
Moderna USD 1.31M 98.69M Sep/2026
Nektar Therapeutics USD 10.86M 10.95M Mar/2026
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Neurocrine Biosciences USD 1.12B 161M Sep/2026
Novartis USD 14.52B 112M Sep/2026
OPKO Health USD 163.58M 39.38M Jun/2026
Organigram Holdings CAD 105.78M 45.99M Jun/2026
Pfizer USD 16.6B 1.57B Sep/2026
Pharma Mar EUR 54.2M 4.2M Sep/2026
PTC Therapeutics USD 357.8M 3.2M Sep/2026
Qiagen NV USD 487.78M 24.66M Sep/2026
Regeneron Pharmaceuticals USD 5.12B 830M Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sarepta Therapeutics USD 381.4M 19.9M Sep/2026
Sartorius EUR 926.3M 14.5M Sep/2026
Sino Biopharmaceutical CNY 19.44B 5.18B Jun/2026
Tilray USD 217.51M 74.75M Dec/2025
Ultragenyx Pharmaceutical USD 173M 41M Sep/2026
Vertex Pharmaceuticals USD 3.44B 110M Sep/2026
Zealand Pharma A/S 34M 34.92M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 1.78B 50M Sep/2026